EARLY ALZHEIMER´S DISEASE
Clinical trials for EARLY ALZHEIMER´S DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMER´S DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMER´S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to slow Alzheimer's: phase 2 trial underway
Disease control Recruiting nowThis Phase 2 trial tests whether TTYP01 tablets can slow cognitive decline in people with early Alzheimer's disease. About 180 participants aged 60-85 with mild cognitive impairment or mild dementia will receive either a low dose, high dose, or placebo for 78 weeks. Researchers w…
Matched conditions: EARLY ALZHEIMER´S DISEASE
Phase: PHASE2 • Sponsor: Shanghai Auzone Biological Technology Co., Ltd. • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
Could one stem cell infusion slow Alzheimer's decline?
Disease control Recruiting nowThis study tests whether adding a single infusion of human stem cells to standard antibody therapy can slow memory and thinking decline in people with mild Alzheimer's or mild cognitive impairment. Ten participants aged 55-90 who are already on antibody treatment will receive one…
Matched conditions: EARLY ALZHEIMER´S DISEASE
Phase: PHASE2 • Sponsor: Bernard (Barry) Baumel • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
Could this drug slow Alzheimer's brain damage?
Disease control Recruiting nowThis study tests an experimental drug called MK-2214 in 340 people with early Alzheimer's disease. The goal is to see if it can slow the buildup of a harmful protein called tau in the brain, which damages brain cells. Participants will receive either the drug or a placebo, and re…
Matched conditions: EARLY ALZHEIMER´S DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC